Are RLMD insiders buying or selling?

Between Sep 10, 2026 and Sep 09, 2026, 2 Relmada Therapeutics, Inc. insiders made 4 open-market purchases worth $1.7M and no sales, a net purchase of $1.7M.

How much RLMD stock have insiders bought and sold in the last two years?

Between Jul 01, 2024 and Jun 30, 2026, 5 Relmada Therapeutics, Inc. insiders made 25 open-market purchases worth $3.6M and no sales. In the four quarters to Jun 30, 2026: 9 purchases ($2.5M) and no sales. The largest purchase was Shenouda Maged buying $1.1M on Nov 05, 2025.

What was the largest recent RLMD insider trade?

Shenouda Maged (Chief Financial Officer) bought $504.8K of RLMD stock on Sep 09, 2026 at about $4.20 a share.

When did an insider last buy RLMD shares?

The most recent open-market purchase on file is Traversa Sergio (Chief Executive Officer · Director) buying $410K on Sep 10, 2026. The largest purchase in the period was $504.8K by Shenouda Maged.

Where does RLMD insider trading data come from?

From the Form 4 filings Relmada Therapeutics, Inc.'s officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.

RLMD

Relmada Therapeutics, Inc.

Insiders buying nowCIK 1553643

Relmada Therapeutics, Inc. insider trading

Insiders at Relmada Therapeutics, Inc. have been buying its stock on the open market. The largest purchase in the last 30 days was Shenouda Maged (Chief Financial Officer) buying $504.8K of RLMD, filed Sep 11, 2026. Every open-market purchase and sale its officers, directors and 10% owners filed in that time is listed below, each linked to the original Form 4.

Bought on the open market: $1.7M
Sold: —
Insiders: 2
Latest trade: Sep 09, 2026

From SEC filings · last 30 days

Recent RLMD insider transactions

Shenouda MagedChief Financial Officer
Bought 120,200 sh at $4.20 · Sep 09, 2026
$504.8K
Filing
Traversa SergioChief Executive Officer · Director
Bought 100,000 sh at $4.18 · Sep 09, 2026
$418K
Filing
Traversa SergioChief Executive Officer · Director
Bought 100,000 sh at $4.10 · Sep 10, 2026
$410K
Filing
Shenouda MagedChief Financial Officer
Bought 79,800 sh at $4.25 · Sep 10, 2026
$339.2K
Filing

SEC Form 4 data, Q3 2024 to Q2 2026

RLMD insider trading by quarter

Between Jul 01, 2024 and Jun 30, 2026, 5 insiders traded RLMD on the open market: 25 purchases worth $3.6M and 0 sales. In the last four quarters alone: 9 purchases ($2.5M) and 0 sales, by 4 insiders.

Quarter	Bought	Sold	Insiders
Q2 2026	—	—	—
Q1 2026	—	—	—
Q4 2025	+$2.4M6 buys	—	4
Q3 2025	+$178.1K3 buys	—	1
Q2 2025	+$461.6K8 buys	—	4
Q1 2025	—	—	—
Q4 2024	—	—	—
Q3 2024	+$642.8K8 buys	—	4

Largest purchase: +$1.1M of RLMD by Shenouda Maged (Chief Financial Officer) on Nov 05, 2025.

Open-market transactions through Jun 30, 2026most recent first

Traversa Sergio
Chief Executive Officer · Director
+$113.3K
Dec 15, 2025
27,500 sh · $4.12
Shenouda Maged
Chief Financial Officer
+$48.1K
Dec 15, 2025
11,665 sh · $4.12
Shenouda Maged
Chief Financial Officer
+$1.1M
Nov 05, 2025
500,000 sh · $2.20
Traversa Sergio
Chief Executive Officer · Director
+$599.5K
Nov 05, 2025
272,500 sh · $2.20
Ence Chuck
CAO and COO
+$299.2K
Nov 05, 2025
136,000 sh · $2.20
Kelly Paul Edward
Chief Operating Officer · Director
+$198K
Nov 05, 2025
90,000 sh · $2.20
Traversa Sergio
Chief Executive Officer · Director
+$41.4K
Aug 28, 2025
55,976 sh · $0.74
Traversa Sergio
Chief Executive Officer · Director
+$86.7K
Aug 27, 2025
129,455 sh · $0.67
Traversa Sergio
Chief Executive Officer · Director
+$49.9K
Aug 26, 2025
80,545 sh · $0.62
Traversa Sergio
Chief Executive Officer · Director
+$82.7K
May 20, 2025
147,686 sh · $0.56
Shenouda Maged
Chief Financial Officer
+$31.2K
May 20, 2025
60,000 sh · $0.52
Shenouda Maged
Chief Financial Officer
+$44.1K
May 19, 2025
90,000 sh · $0.49
Traversa Sergio
Chief Executive Officer · Director
+$15K
May 19, 2025
30,000 sh · $0.50
Ence Chuck
CA and CO
+$103K
May 16, 2025
228,960 sh · $0.45
Kelly Paul Edward
Chief Operating Officer · Director
+$86K
May 16, 2025
200,000 sh · $0.43

Date	Insider	Shares	Price	Value
Dec 15, 2025	Traversa SergioChief Executive Officer · Director	27,500	$4.12	+$113.3K
Dec 15, 2025	Shenouda MagedChief Financial Officer	11,665	$4.12	+$48.1K
Nov 05, 2025	Shenouda MagedChief Financial Officer	500,000	$2.20	+$1.1M
Nov 05, 2025	Traversa SergioChief Executive Officer · Director	272,500	$2.20	+$599.5K
Nov 05, 2025	Ence ChuckCAO and COO	136,000	$2.20	+$299.2K
Nov 05, 2025	Kelly Paul EdwardChief Operating Officer · Director	90,000	$2.20	+$198K
Aug 28, 2025	Traversa SergioChief Executive Officer · Director	55,976	$0.74	+$41.4K
Aug 27, 2025	Traversa SergioChief Executive Officer · Director	129,455	$0.67	+$86.7K
Aug 26, 2025	Traversa SergioChief Executive Officer · Director	80,545	$0.62	+$49.9K
May 20, 2025	Traversa SergioChief Executive Officer · Director	147,686	$0.56	+$82.7K
May 20, 2025	Shenouda MagedChief Financial Officer	60,000	$0.52	+$31.2K
May 19, 2025	Shenouda MagedChief Financial Officer	90,000	$0.49	+$44.1K
May 19, 2025	Traversa SergioChief Executive Officer · Director	30,000	$0.50	+$15K
May 16, 2025	Ence ChuckCA and CO	228,960	$0.45	+$103K
May 16, 2025	Kelly Paul EdwardChief Operating Officer · Director	200,000	$0.43	+$86K

From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.

Don't check RLMD — let it ping you

Watch every insider filing the minute it clears the SEC

The live dashboard reads every Form 4 as it lands and puts it in plain English — open-market buys, cluster buys where several insiders move at once, and the sales executives chose to make rather than scheduled. Free to open; Pro adds alerts, watchlists and each buyer's track record.

Open RLMD on the live dashboard Filings on SEC.gov

Relmada Therapeutics, Inc. is outside the ~660 companies InsiderPulse scans continuously. This page is built from the filings on the live tape and stays up while its insiders are buying. Monitoring, not advice.

Other companies insiders are buying now

SELF SLRC TNON TPL TYRA USLM AOMR ARQ ATEC ATLO BGDE BRN CBU CLPR CRT CSBB

Questions

Are RLMD insiders buying or selling?: Between Sep 10, 2026 and Sep 09, 2026, 2 Relmada Therapeutics, Inc. insiders made 4 open-market purchases worth $1.7M and no sales, a net purchase of $1.7M.
How much RLMD stock have insiders bought and sold in the last two years?: Between Jul 01, 2024 and Jun 30, 2026, 5 Relmada Therapeutics, Inc. insiders made 25 open-market purchases worth $3.6M and no sales. In the four quarters to Jun 30, 2026: 9 purchases ($2.5M) and no sales. The largest purchase was Shenouda Maged buying $1.1M on Nov 05, 2025.
What was the largest recent RLMD insider trade?: Shenouda Maged (Chief Financial Officer) bought $504.8K of RLMD stock on Sep 09, 2026 at about $4.20 a share.
When did an insider last buy RLMD shares?: The most recent open-market purchase on file is Traversa Sergio (Chief Executive Officer · Director) buying $410K on Sep 10, 2026. The largest purchase in the period was $504.8K by Shenouda Maged.
Where does RLMD insider trading data come from?: From the Form 4 filings Relmada Therapeutics, Inc.'s officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.

Get the free Insider Brief

The week's real signals — open-market insider buys, cluster formations and what insiders did in RLMD and across the market — in plain English, with grants and routine vesting stripped out. Free, and honest about what the data can and cannot say.